Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 37.15 as of Sunday, July 26, 2026.
Forward PE Ratio (37.15) = Close Price ($544.32) / Consensus Forward EPS ($14.65)
FORWARD PE RATIO
37.15
SECTOR MEDIAN · HEALTHCARE
18.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+102.07%
vs the sector median at left
IDEXX Laboratories, Inc.
Market Cap
$42.94B
Forward PE Ratio
37.15
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $42.94B | 37.15 |
| Agilent Technologies, Inc. (A)vs › | $39.14B | 22.88 |
| Humana Inc. (HUM)vs › | $46.74B | 43.48 |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 27.52 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 36.45 |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 16.24 |
| Medline Inc. (MDLN)vs › | $32.77B | 25.58 |
| Cardinal Health, Inc. (CAH)vs › | $53.41B | 21.16 |
| Zoetis Inc. (ZTS)vs › | $31.59B | 10.95 |
| Centene Corp. (CNC)vs › | $31.31B | 18.05 |
Trailing P/E
40.1
reported TTM EPS
Forward P/E
37.1
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $14.65 implies +8.0% EPS growth vs the reported trailing $13.56.
At today's $544.32 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $14.65 | $14.49 – $14.77 | 10 | 37.2x |
| 2027-12-31 | $16.56 | $16.23 – $16.91 | 10 | 32.9x |
| 2028-12-31 | $18.75 | $17.90 – $19.76 | 8 | 29.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
